← Leaderboards
Robert L Camp
Yale University
$1,017,484
Attributed
$1,017,484
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $256.7K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,017,484 · 3
By mechanism
K08$553,521 · 1
R21$463,963 · 2
Top collaborators
No co-investigators on record.
Most similar at Yale University
Same institution · by research overlap
- John J Wysolmerski$21,872,124
- Michael H Nathanson$44,568,855
- Stephen M Strittmatter$76,187,371
- Hugh S Taylor$17,818,952
- Rajita Sinha$53,551,446
Others in their field
Top investigators on “Neoplasm /Cancer Relapse /Recurrence”
- Charles A Coltman · Southwest Oncology Group$124,661,867
- Philip J Disaia · University Of California Irvine$19,978,203
- John P Pierce · University Of California San Diego$18,652,168
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Daniel W Nixon · Medical University Of South Carolina$16,979,710
- Robert C Park · American College Of Ob And Gyn$16,339,593
Research focus
Neoplasm /Cancer Relapse /RecurrencePathologic ProcessGene ExpressionClinical ResearchGrowth FactorBreast NeoplasmsMicroarray TechnologyGrowth Factor ReceptorsCell ProliferationMetastasisHuman SubjectHuman TissueEvolutionMalignant NeoplasmsEngineeringCellsDisruptionIn VitroIntracellular Protein TransportDiagnosticLocalizedLocationCell FixingIn Situ
Grant awards (8)
Novel Methods to localize protein-protein interactions in fixed cells and tissues$186,047
R21 · FY2008 · CA · contact PI
Qualitative Analysis of Tissue Biomarkers and Pathways$137,306
R21 · FY2006 · CA · contact PI
Qualitative Analysis of Tissue Biomarkers and Pathways$140,610
R21 · FY2005 · CA
Analysis of Late Recurrence in Breast Cancer$116,048
K08 · FY2005 · ES
Analysis of Late Recurrence in Breast Cancer$113,297
K08 · FY2004 · ES
Analysis of Late Recurrence in Breast Cancer$110,627
K08 · FY2003 · ES
Analysis of Late Recurrence in Breast Cancer$108,033
K08 · FY2002 · ES
Analysis of Late Recurrence in Breast Cancer$105,516
K08 · FY2001 · ES